Used primarily in the treatment of advanced prostate cancer, especially when other therapies have failed. It combines the effects of a chemotherapy agent and a hormone therapy, targeting cancer cells through multiple mechanisms. The compound interferes with cell division by disrupting microtubule function, leading to cancer cell death. It is particularly effective in slowing tumor growth and managing symptoms in metastatic prostate cancer. Often prescribed when the cancer has spread to other parts of the body, it helps prolong survival and improve quality of life in affected patients.